Evolent Health (EVH) Revenue (2015 - 2026)

Evolent Health has reported Revenue for 12 years, with the latest figure at $652.5 million in Q2 2026.

• On a quarterly basis, Revenue rose 46.86% year-over-year to $652.5 million in Q2 2026; TTM through Jun 2026 was $2.1 billion, a 4.5% decrease from a year earlier, with the FY2025 full-year figure at $1.9 billion, down 26.56% from the prior year.
• Revenue was $652.5 million for Q2 2026 at Evolent Health, up from $496.2 million in the prior quarter.
• The five-year high for Revenue was $652.5 million in Q2 2026, with the low at $297.1 million in Q1 2022.
• Average Revenue over 5 years is $494.2 million, with a median of $481.6 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2025: Revenue soared 58.49% in 2022, then tumbled 31.34% in 2025.
• Over 5 years, Revenue stood at $382.4 million in 2022, then surged by 45.4% to $556.1 million in 2023, then grew by 16.27% to $646.5 million in 2024, then dropped by 27.5% to $468.7 million in 2025, then surged by 39.21% to $652.5 million in 2026.
• The last three Revenue figures came in at $652.5 million (Q2 2026), $496.2 million (Q1 2026), and $468.7 million (Q4 2025), per Business Quant data.